Millions of prescription eye drops recalled nationwide over contamination concerns

Millions of prescription steroid eye drops have been recalled nationwide due to potential contamination issues, prompting the FDA to classify the recall as a Class II action. This means the product may cause temporary or medically reversible adverse health conditions or where the probability of adverse health consequences is remote. Lupin, the manufacturer behind the affected drops, initiated the voluntary recall. Consumers are advised to check the lot numbers of their eye drops and consider alternative treatments if they find themselves affected by this recall. This move underscores the importance of stringent safety standards in pharmaceutical products.